NCT01790087View on ClinicalTrials.gov

ANX-188 Thorough QT/QTc Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

June 30, 2013

Conditions
Healthy
Interventions
DRUG

ANX-188 Therapeutic Dose

DRUG

ANX-188 Supratherapeutic dose

DRUG

Saline

DRUG

Moxifloxacin

Trial Locations (1)

20201

Research Site, Baltimore

Sponsors
All Listed Sponsors
lead

Mast Therapeutics, Inc.

INDUSTRY

NCT01790087 - ANX-188 Thorough QT/QTc Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter